Skip to content

Dr. Reddy's marks 25 years on NYSE with closing bell ringing

"We remain unwavering in our purpose: accelerating access to affordable and innovative healthcare, because Good Health Can’t Wait.”

NEW YORK — Dr. Reddy’s Laboratories Ltd. rang the closing bell at the New York Stock Exchange on May 29 to mark two and a half decades of being on the Big Board.

“When Dr. K. Anji Reddy founded this company, his vision was simple but powerful: bring affordable, innovative medicines to patients everywhere," said chairman Satish Reddy. "That vision drove our NYSE debut in 2001 and continues to shape who we are today, a trusted name in the U.S. market, backed by differentiated products and consistent operations.

"This milestone belongs to our employees, our partners, and our shareholders. As we look ahead, we remain unwavering in our purpose: accelerating access to affordable and innovative healthcare, because Good Health Can’t Wait.”

Submit Your Press Release

Have news to share? Send us your press releases and announcements.

Send Press Release

Latest